IMPACT-TD Registry

Advertisement

cGxPJobs Banner

Teva Presents New AUSTEDO Data Supporting Sustained TD Treatment

PARSIPPANY, New Jersey, USA & TEL AVIV, Israel – June 8, 2026 Teva Pharmaceuticals has unveiled new real-world and...

By cGxPwire Editor
June 9, 2026

Read More

Teva Uncovers Widespread Underdiagnosis of Tardive Dyskinesia in Young Patients

PARSIPPANY, N.J. and TEL AVIV, Israel, May 18, 2026 Teva Pharmaceuticals has announced new findings from its ongoing IMPACT-TD...

By cGxPwire Editor
May 20, 2026

Read More

Advertisement

cGxPJobs

Directory